Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Dr Jay and Quest Clinical Research Elsewhere ot

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154913
(Total Views: 3143)
Posted On: 05/23/2024 11:15:20 AM
Posted By: Plotinus
Dr Jay and Quest Clinical Research

Elsewhere others have noted and I can confirm Dr J put an end date of May 2024 to his LinkedIn profile for Quest Clinical Research. I use LinkedIn and the end dates don’t show up accidentally, they are established intentionally. That is his baby and there is nothing official, but if Dr J is handing over the reigns to the research organization he founded and under which he has performed countless clinical trials it would be for a good reason.

Dr J I believe is not singularly focused on money. I mentioned the below quote recently regarding Merck and you’ll recall PD-1 inhibitors don’t treat 85% of CCR to say nothing of other clinically devastating high CCR5 expressing tumors such as pancreatic and glioblastoma.

“ With Merck reporting a whopping $25 billion sales haul for Keytruda on Thursday, the PD-1 cancer superstar appears to be the world's top-selling drug in 2023.”

I am ill- equipped to get into Dr. Jay’s psyche and try to divine intentions but previous actions strongly suggest he is a healer first and wants Leronlimab in the hands of clinicians as a first order priority. Perhaps there is a juggernaut BP that has come knocking and dictating reasonable terms that go beyond money…”but we will need you fully committed”. It is why companies buy “key man” insurance. Yes, let’s make this happen, we will give you the keys to our treasury and vast resources but you must be Master and Commander to guide the trial…full time.

Dr. Jay has to have a good reason to step back from his baby if that is what is happening. This scenario would be a good reason. This would be a legacy, not in money although that is assumed, but in bringing Elysium to an honest man who wants to make a real difference to humanity and the many infirmities for which Leronlimab can make a difference.


(36)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us